Rare Disease COXPD12: A Case Study of a 6-Month-Old Infant
A Remarkable Discovery of the Rare Disease COXPD12
Recently, news emerged from Cambridgeshire, UK, about a 6-month-old infant diagnosed with COXPD12, an extremely rare genetic disorder. Initially thought to have a milk allergy, the true underlying condition was eventually revealed. The baby's mother, Emma Rowe, faced feeding difficulties after the birth of her daughter, Rosie, leading to multiple hospital visits.
Challenges at the Hospital
Medical professionals initially diagnosed Rosie's symptoms as reflux and a milk protein allergy, prescribing a special formula. However, Rosie's condition did not improve after switching formulas. She began losing weight, her smiles faded, and her ability to hold her head up weakened. Eventually, Rosie was rushed to the emergency room and admitted for further tests.
What is COXPD12?
Tests conducted during her hospital stay revealed that Rosie suffered from severe dysphagia and abnormal muscle tone. Furthermore, an MRI scan showed widespread abnormalities in her white matter. Genetic testing confirmed a diagnosis of COXPD12, a rare mitochondrial disease linked to the EARS2 gene. This condition disrupts the body's energy production process, potentially affecting the brain and nervous system.
Symptoms and Progression of COXPD12
COXPD12 is a very rare genetic disorder caused by mitochondrial dysfunction. Symptoms typically appear within the first few months of life and can include:
- Low muscle tone
- Feeding difficulties
- Developmental delay
- Motor skill regression
This condition is an autosomal recessive disorder, meaning it can occur if both parents are carriers. The estimated global prevalence of COXPD12 is less than 1 in a million, with no specific statistics reported in South Korea.
Future Outlook and Family's Efforts
Rosie is now 7 months old, and her future prognosis remains uncertain. Emma and her husband, Harry, are actively fundraising for their daughter's specialized treatment and potential participation in future clinical trials. They hope to raise awareness about this rare disease and encourage further research. We encourage you to send your support to this precious baby and her family.
